Bayesian two-stage design for phase II oncology trials with binary endpoint

DOI10.1002/SIM.9355zbMATH Open1547.62179MaRDI QIDQ6628369

Yanpeng Wu, Pingyan Chen, Jianhong Pan, Jun Zhao, Jing-Xian Wang, Fangyao Chen, Lichang Chen

Publication date: 29 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

posterior probabilityBayesianpredictive probabilitySimon's two-stage designbinary endpoint

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints
• Bayesian enhancement two-stage design with error control for phase II clinical trials

This page was built for publication: Bayesian two-stage design for phase II oncology trials with binary endpoint

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628369)